InterMune, Inc. (ITMN)
- Nasdaq: ITMN
- Mkt.Cap.:644.87M
Sector Pure-Play:
Healthcare > Biopharmaceuticals (^BPHRM)
Healthcare > Biopharmaceuticals (^BPHRM) Classification
| Sector | |
|---|---|
Healthcare |
|
Biopharmaceuticals |
|

- - Focused

- - Sector Pure-Play
Sector companies
Top 5 competitive companies in Biopharmaceuticals (^BPHRM) :
| Ticker | Name | Mkt.Cap. |
|---|---|---|
| PFE | Pfizer Inc. | 133.11B |
| NVS | Novartis AG (ADR) | 122.38B |
| RHHBY | Roche Holding Ltd. (ADR) | 121.62B |
| MRK | Merck & Co., Inc. | 110.07B |
| GSK | GlaxoSmithKline plc (ADR) | 101.52B |
Relationships
Sample 8 relationships grouped by relationhip type.
| Ticker | Name | |
|---|---|---|
| Competitors | ||
![]() | GILD | Gilead Sciences, Inc. |
![]() | GSK | GlaxoSmithKline plc (ADR) |
| Customers | ||
![]() | CVS | CVS Caremark Corporation |
![]() | ESRX | Express Scripts, Inc. |
| Suppliers | ||
![]() | AMGN | Amgen, Inc. |
![]() | CAH | Cardinal Health, Inc. |
| Partners | ||
![]() | AMGN | Amgen, Inc. |
![]() | CAH | Cardinal Health, Inc. |

- - Defined by the Company

- - Defined by Others
Products & Services
Sample products & services from Biopharmaceuticals (^BPHRM) :
- Actimmune (Interferon Gamma-1b)
- Esbriet (Pirfenidone)
- Hepatology Compound
Relative Performance (1Y)
- InterMune, Inc. (ITMN)
- S&P 500 INDEX (SPX)
- Healthcare > Biopharmaceuticals (^BPHRM)
Subscribe to an RSS Feed Research Reports
- Competitors by Product for InterMune, Inc. (ITMN) Revere - Sep 04, 2010 - HTML - $75.00 - Add to Cart »
- Drug/Medical Device for InterMune, Inc. (ITMN) Revere - Sep 04, 2010 - PDF - $70.00 - Add to Cart »
- FDA Approval Decisions Report for April, 2010 Revere - Apr 01, 2010 - ZIP - $125.00 - Add to Cart »
- FDA Approval Decisions Report for June, 2010 Revere - Jun 01, 2010 - ZIP - $125.00 - Add to Cart »
- FDA Approval Decisions Report for March, 2010 Revere - Mar 01, 2010 - ZIP - $125.00 - Add to Cart »
Healthcare
Biopharmaceuticals